相似文献
1
Stability studies needed to define the handling and transport conditions of sensitive pharmaceutical or biotechnological products.
AAPS PharmSciTech. 2011 Dec;12(4):1264-75. doi: 10.1208/s12249-011-9684-0. Epub 2011 Sep 27.
2
Quality control and analytical techniques for biopharmaceuticals.
Bioanalysis. 2011 Jan;3(1):81-95. doi: 10.4155/bio.10.161.
3
Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment.
PDA J Pharm Sci Technol. 2007;61(2 Suppl TR 39):2-19.
4
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
World Health Organ Tech Rep Ser. 2015(992):1-210, back cover.
5
One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
J Biopharm Stat. 2015;25(2):307-16. doi: 10.1080/10543406.2014.972743.
6
WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser. 2009(953):1-161.
7
Technical report # 39: cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Parenteral Drug Association.
PDA J Pharm Sci Technol. 2005 Sep-Oct;59(3 Suppl TR39):1-12.
8
Integration of temperature-controlled requirements into pharmacy practice.
J Am Pharm Assoc (2003). 2009 May-Jun;49(3):e61-7; quiz e68-9. doi: 10.1331/JAPhA.2009.08140.
9
Application of the near-infrared spectroscopy in the pharmaceutical technology.
J Pharm Biomed Anal. 2012 Jul;66:1-10. doi: 10.1016/j.jpba.2012.03.009. Epub 2012 Mar 15.
10
Re-processing of biological products: regulatory considerations from the CBER perspective.
Dev Biol (Basel). 2003;113:105-7; discussion 115-6.
引用本文的文献
1
Unravelling the influence of choline chloride-based deep eutectic solvents on lysozyme: a comparative study of fructose and formic acid donors.
RSC Adv. 2025 Jul 18;15(31):25483-25496. doi: 10.1039/d5ra02315g. eCollection 2025 Jul 15.
2
Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability.
MAbs. 2025 Dec;17(1):2512211. doi: 10.1080/19420862.2025.2512211. Epub 2025 May 28.
3
Assessment of the Effects of Ionizing Radiation on Biologic Drugs: mAb Product Quality and Risk Evaluation for Global Shipping Logistics.
Pharm Res. 2025 May 16. doi: 10.1007/s11095-025-03867-7.
4
Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study.
ACS Omega. 2025 Jan 3;10(1):1207-1225. doi: 10.1021/acsomega.4c08669. eCollection 2025 Jan 14.
5
Regulatory Considerations for Stability Studies of Co-Processed Active Pharmaceutical Ingredient.
AAPS J. 2024 Dec 17;27(1):16. doi: 10.1208/s12248-024-00995-7.
6
Temperature Excursion Management: A Tier-Based Approach for Commercial Oral Solid Dosage Forms.
AAPS J. 2024 Oct 1;26(6):108. doi: 10.1208/s12248-024-00976-w.
7
Stability of Protein Pharmaceuticals: Recent Advances.
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
8
Cold Denaturation of Proteins in the Absence of Solvent: Implications for Protein Storage.
Angew Chem Weinheim Bergstr Ger. 2022 Jun 20;134(25):e202115047. doi: 10.1002/ange.202115047. Epub 2022 Apr 21.
9
Molecular Docking and ADMET Analysis Strategy-based Stability Indicating RP-HPLC-PDA Method Development and Validation of Toremifene.
Curr Comput Aided Drug Des. 2025;21(5):680-693. doi: 10.2174/0115734099289409240307042531.
10
Cold Denaturation of Proteins in the Absence of Solvent: Implications for Protein Storage.
Angew Chem Int Ed Engl. 2022 Jun 20;61(25):e202115047. doi: 10.1002/anie.202115047. Epub 2022 Apr 21.
本文引用的文献
1
Technical report # 39: cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Parenteral Drug Association.
PDA J Pharm Sci Technol. 2005 Sep-Oct;59(3 Suppl TR39):1-12.
Zotero 插件